FRAGMIN Drug Patent Profile
✉ Email this page to a colleague
When do Fragmin patents expire, and what generic alternatives are available?
Fragmin is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in FRAGMIN is dalteparin sodium. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dalteparin sodium profile page.
Summary for FRAGMIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 37 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for FRAGMIN |
What excipients (inactive ingredients) are in FRAGMIN? | FRAGMIN excipients list |
DailyMed Link: | FRAGMIN at DailyMed |
Recent Clinical Trials for FRAGMIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Itreas | Phase 3 |
IQVIA Biotech | Phase 3 |
Anthos Therapeutics, Inc. | Phase 3 |
Pharmacology for FRAGMIN
Drug Class | Anti-coagulant Low Molecular Weight Heparin |
Anatomical Therapeutic Chemical (ATC) Classes for FRAGMIN
US Patents and Regulatory Information for FRAGMIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | FRAGMIN | dalteparin sodium | INJECTABLE;INJECTION | 020287-008 | Apr 4, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | FRAGMIN | dalteparin sodium | INJECTABLE;SUBCUTANEOUS | 020287-012 | Mar 15, 2022 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | FRAGMIN | dalteparin sodium | INJECTABLE;SUBCUTANEOUS | 020287-005 | Apr 4, 2002 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FRAGMIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | FRAGMIN | dalteparin sodium | INJECTABLE;SUBCUTANEOUS | 020287-004 | Jan 30, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | FRAGMIN | dalteparin sodium | INJECTABLE;SUBCUTANEOUS | 020287-001 | Dec 22, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | FRAGMIN | dalteparin sodium | INJECTABLE;SUBCUTANEOUS | 020287-003 | Mar 18, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FRAGMIN
See the table below for patents covering FRAGMIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
U.S.S.R. | 1209033 | "CПOCOБ ПOЛУЧEHИЯ ДEПOЛИMEPИЗOBAHHOГO ГEПAPИHA" (METHOD OF PRODUCING DEPOLYMERIZED HEPARIN) | ⤷ Try a Trial |
Netherlands | 930104 | ⤷ Try a Trial | |
Denmark | 160764 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |